...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Exempt Distributions - Dec 9, 2022 & Jan 13, 2023

Jan 13, 2023:Total Value $545.549.82

A mixed bag Of

-A Promissory Note with warrants

-Common Shares with no Warrants (CS:$1.34)

-Common Shares with 1/2 warrants (CS:$1.34)

-Common Shares with 2 warrants    (CS:$0.85)

Dec 9, 2022:Total Value $410,958.90

-Promissory Note with warrants

Note: Both of the above exempt distributions are primarily out of Alberta.

         Warrants expire in 2028.

 

Koo

Share
New Message
Please login to post a reply